SMTL ID : 6mo4.1

Co-Crystal structure of P. aeruginosa LpxC-50067 complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.84 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 4 residues within 4Å: Chain A: H.82, H.241, D.245 Ligands: JWM.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.82, A:H.241, A:D.245, A:D.245

1 x JWM: N-[(2R)-1-(hydroxyamino)-3-methyl-3-(methylsulfonyl)-1-oxobutan-2-yl]-4-(6-hydroxyhexa-1,3-diyn-1-yl)benzamide(Non-covalent)

JWM.2: 18 residues within 4Å: Chain A: L.22, H.23, M.66, E.81, H.82, T.194, F.195, G.196, I.201, A.210, G.213, S.214, A.218, V.220, H.241, D.245, H.268 Ligands: MG.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.22, A:L.22, A:T.194, A:F.195, A:I.201, A:A.210, A:A.218, A:V.220 Hydrogen bonds: A:M.66, A:H.82, A:T.194, A:T.194

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cohen, F. et al., Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety. Chemmedchem (2019)

Release Date

2019-07-17

Peptides

UDP-3-O-acyl-N-acetylglucosamine deacetylase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

UDP-3-O-acyl-N-acetylglucosamine deacetylase